Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$7.80 Mil
% of Total Estimate Gain
32.26%

Saturn V Capital Management LP's Cytokinetics Inc Holding Summary

As of 2025-03-31, Saturn V Capital Management LP held - shares of Cytokinetics Inc(CYTK), totaling N/A. This investment constitutes 0% of their stock portfolio, and Saturn V Capital Management LP now holds 0% of the outstanding Cytokinetics Inc(CYTK) stock.

The initial trade took place in 2022Q4. And since then Saturn V Capital Management LP has made 6 purchases of CYTK, at an average price of $41.70, for a total of 579,831.00 shares. In addition, there have been 3 sales at an average price of $55.15 for 579,831.00 shares. Based on historical transaction data and CYTK's current price of $37.31, Saturn V Capital Management LP's estimated gain on his CYTK holdings is $7.80 Mil, reflecting a 32.26% gain to date.

Saturn V Capital Management LP CYTK ($37.31) Holding Chart

Saturn V Capital Management LP CYTK ($37.31) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1